A model using easily evaluated clinical features to identify triple negative breast cancer (TNBC) patients (pts) with high probability of achieving pathologic complete response (pCR) to neoadjuvant systemic therapy (NAST). (March 2019) - Moulder, S.; Adrada, B.; Lim, B.; Ueno, N.; Candelaria, R.; Rauch, G.; Litton, J.; Thompson, A.; Huo, L.; Hess, K.